Patents Assigned to Maine Medical Center
  • Publication number: 20030219844
    Abstract: A compound is provided having the formula: 1
    Type: Application
    Filed: June 10, 2003
    Publication date: November 27, 2003
    Applicant: Maine Medical Center
    Inventors: Alexander A. Waldrop, Calvin P.H. Vary
  • Patent number: 6630325
    Abstract: The invention relates to novel nucleic acids encoding a mammalian adventitia inducible and bone expressed gene designated REMODEL, and proteins encoded thereby, whose expression is increased in certain diseases, disorders, or conditions, including, but not limited to, negative remodeling, arterial restenosis, vessel injury, ectopic ossification, fibrosis, and the like. REMODEL also plays a role in cell-cell and cell-matrix adhesion, bone density, bone formation, dorsal closure, and is associated with spina bifida-like phenotype. The invention further relates to methods of treating and detecting these diseases, disorders or conditions, comprising modulating or detecting REMODEL expression and/or production of REMODEL polypeptide.
    Type: Grant
    Filed: October 19, 2000
    Date of Patent: October 7, 2003
    Assignee: Maine Medical Center Research Institute
    Inventors: Volkhard Lindner, Robert E. Friesel
  • Patent number: 6607911
    Abstract: The invention relates to novel control DNA constructs, and methods and kits for using and making the same, which provide comprehensive controls useful for quality assurance in the diagnostic detection of complex genetic diseases such as, but not limited to, cystic fibrosis, and for quality assurance in nucleic acid assays to detect components associated with an environmental condition or a biological organism.
    Type: Grant
    Filed: May 25, 2001
    Date of Patent: August 19, 2003
    Assignees: Maine Molecular Quality Controls, Inc., Maine Medical Center Research Institute
    Inventors: Joan Gordon, Clark A. Rundell
  • Publication number: 20030083465
    Abstract: This invention relates to therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids, and on the role of their signaling pathway in endothelial cell migration and/or differentiation. In addition, this invention provides a substantially purified Jagged protein, as well as a substantially purified nucleic acid molecule or segment thereof encoding Jagged protein, or a functionally equivalent derivative, or allelic or species variant thereof.
    Type: Application
    Filed: August 6, 2002
    Publication date: May 1, 2003
    Applicant: Maine Medical Center Research Institute
    Inventors: Ann B. Zimrin, Thomas MaCiag, Michael S. Pepper, Roberto Montesano, Michael Wong
  • Patent number: 6433138
    Abstract: This invention relates to therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids, and on the role of their signaling pathway in endothelial cell migration and/or differentiation. In addition, this invention provides a substantially purified Jagged protein, as well as a substantially purified nucleic acid molecule or segment thereof encoding Jagged protein, or a functionally equivalent derivative, or allelic or species variant thereof.
    Type: Grant
    Filed: November 25, 1998
    Date of Patent: August 13, 2002
    Assignee: Maine Medical Center Research Institute
    Inventors: Ann B. Zimrin, Michael Wong, Thomas Maciag, Michael S. Pepper, Roberto Montesano
  • Patent number: 6074825
    Abstract: Stable reference nucleic acid for use in all steps of molecular screening and diagnostic assays and method of making. A desired nucleic acid sequence is amplified, ligated into an expression vector, and used to transform a vehicle. A cellular vehicle is subsequently killed without affecting the encapsulated nucleic acid. The vehicle membrane is stabilized under controlled conditions to a stability substantially matching that of a test cell membrane. The recovered nucleic acid is used as a standard or control in molecular diagnostic and genetic testing assays.
    Type: Grant
    Filed: July 31, 1997
    Date of Patent: June 13, 2000
    Assignee: Maine Medical Center
    Inventors: Clark A. Rundell, Calvin P. H. Vary
  • Patent number: 5994078
    Abstract: Stable reference nucleic acid for use in all steps of molecular screening and diagnostic assays and method of making. A desired nucleic acid sequence is amplified, ligated into an expression vector, and used to transform a vehicle. A cellular vehicle is subsequently killed without affecting the encapsulated nucleic acid. The vehicle membrane is stabilized under controlled conditions to a stability substantially matching that of a test cell membrane. The recovered nucleic acid is used as a standard or control in molecular diagnostic and genetic testing assays.
    Type: Grant
    Filed: December 23, 1997
    Date of Patent: November 30, 1999
    Assignee: Maine Medical Center
    Inventors: Clark A. Rundell, Calvin P. H. Vary
  • Patent number: 5607834
    Abstract: A fluorescent probe including (1) a nucleotide sequence which (a) has a segment complementary to the polynucleotide target and (b) is capable of forming one or more imperfect hairpins with at least one of the hairpins including the just-mentioned segment or a part thereof; and (2) at least one donor fluorophore and at least one acceptor fluorophore covalently attached to the nucleotide sequence so that only when one or more imperfect hairpins are formed, one of the donor fluorophores and one of the acceptor fluorophores are in close proximity to allow resonance energy transfer between them. Also disclosed is a method of using such a probe.
    Type: Grant
    Filed: April 10, 1995
    Date of Patent: March 4, 1997
    Assignee: Maine Medical Center Research Institute
    Inventor: C. Bruce Bagwell